Annual Report to the Nation: Declines in lung cancer, melanoma death rates drive overall cancer mortality drop

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

From 2015 to 2018, the overall cancer death rate in the United States fell by 2.3% per year for men and 2.1% per year for women—an unprecedented drop, led by accelerated decline in deaths from lung cancer and melanoma.

By way of comparatison, the death rate for men dropped 1.8% per year from 2001-2015, and the death rate in women declined 1.4% per year from 2001-2015, according to this year’s Annual Report to the Nation, a study conducted by several federal agencies and cancer groups.

The report, published in JNCI: The Journal of the National Cancer Institute, also finds that overall cancer incidence rates continue to increase among females, children, adolescents and young adults. All trends in this report cover the period before the COVID-19 pandemic.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Alexandria Carolan
Alexandria Carolan
Reporter

YOU MAY BE INTERESTED IN

The College of American Pathologists in collaboration with the International Association for the Study of Lung Cancer, Pulmonary Pathology Society, Association for Molecular Pathology, and the LUNGevity Foundation have developed evidence-based recommendations for the testing of immunotherapy biomarkers, including programmed cell death ligand-1 and tumor mutation burden in patients with non-small cell lung carcinoma.
Alexandria Carolan
Alexandria Carolan
Reporter

Login